Single-dose azithromycin versus benzathine benzylpenicillin for treatment of yaws in children in Papua New Guinea: an open-label, non-inferiority, randomised trial

@article{Mitj2012SingledoseAV,
  title={Single-dose azithromycin versus benzathine benzylpenicillin for treatment of yaws in children in Papua New Guinea: an open-label, non-inferiority, randomised trial},
  author={Oriol Mitj{\`a} and Russell Hays and Anthony Ipai and Moses Penias and Raymond Paru and David Fagaho and Elisa Lazzari and Quique Bassat},
  journal={The Lancet},
  year={2012},
  volume={379},
  pages={342-347}
}

Figures and Tables from this paper

Mass treatment with single-dose azithromycin for yaws.

The prevalence of active and latent yaws infection fell rapidly and substantially 12 months after high-coverage mass treatment with azithromycin, with the reduction perhaps aided by subsequent activities to identify and treat new cases of yaws.

A Trial of Three Rounds of Mass Drug Administration with Azithromycin for Yaws

An open-label cluster-randomized community trial in a yaws-endemic area of Papua New Guinea shows that three rounds of azithromycin MDA 6 months apart are better than one round of azyridine MDA with two rounds of targeted treatment for decreasing the community prevalence of yaws.

Single-dose azithromycin to treat latent yaws.

A Cross-Sectional Study of ‘Yaws’ in Districts of Ghana Which Have Previously Undertaken Azithromycin Mass Drug Administration for Trachoma Control

A cross-sectional survey in thirty communities in two districts of Ghana, previously treated for trachoma, found no evidence of ongoing transmission of yaws and integration of diagnostic testing into both pre and post-MDA surveillance systems is required to better inform yaws control programmes.

Community-based mass treatment with azithromycin for the elimination of yaws in Ghana—Results of a pilot study

A single round of high coverage TCT with azithromycin in a yaws affected sub-district adjoining other endemic areas is effective in reducing the prevalence of seropositive children and the prevalenceof early skin lesions consistent with yaws one year following the intervention.

Impact of Community Mass Treatment with Azithromycin for Trachoma Elimination on the Prevalence of Yaws

The data support expansion of the WHO eradication strategy and suggest an integrated approach to the control of yaws and trachoma in the Pacific may be viable.
...

References

SHOWING 1-10 OF 30 REFERENCES

Single-dose azithromycin versus penicillin G benzathine for the treatment of early syphilis.

Single-dose oral azithromycin is effective in treating syphilis and may be particularly useful in developing countries in which the use of penicillin G benzathine injections is problematic, however, recent reports of azitromycin-resistant Treponema pallidum in the United States indicate the importance of continued monitoring for resistance.

A phase III equivalence trial of azithromycin versus benzathine penicillin for treatment of early syphilis.

The efficacy of azithromycin at a dosage of 2.0 g administered orally was equivalent to that of benzathine penicillin G for the treatment of early syphilis in persons without HIV infection.

A controlled trial of a single dose of azithromycin for the treatment of chlamydial urethritis and cervicitis. The Azithromycin for Chlamydial Infections Study Group.

A single 1-g dose of azithromycin is as effective for the treatment of uncomplicated genital chlamydial infections as a standard seven-day course of doxycycline.

Comparison of azithromycin and ceftriaxone for the treatment of chancroid.

It is concluded that a single 1-g oral dose of azithromycin is as effective as a 250-mg im dose of ceftriaxone for the treatment of chancroid.

Failure of penicillin treatment of yaws on Karkar Island, Papua New Guinea.

Treatment failure was most likely to have been due to reduced susceptibility to penicillin of Treponema pallidum subsp.

Efficacy of a targeted, oral penicillin-based yaws control program among children living in rural South America.

A targeted, oral penicillin-based treatment regimen can successfully treat dermatologic yAWs in individual children and can decrease the prevalence of skin yaws in a community in which it is endemic.

Global Challenge of Antibiotic-Resistant Treponema pallidum

  • L. Stamm
  • Medicine, Biology
    Antimicrobial Agents and Chemotherapy
  • 2009
The genetic basis of T. pallidum macrolide resistance and the potential of this spirochete to develop additional antibiotic resistance that could seriously compromise syphilis treatment and control are discussed.

Efficacy of Single-Dose Azithromycin in Treatment of Acute Otitis Media in Children after a Baseline Tympanocentesis

Children with acute otitis media underwent tympanocentesis and were given a single dose of 30 mg of azithromycin/kg of body weight and clinical cure rates were consistent with historical rates for the 5-day dosing regimen.

A Point Mutation Associated with Bacterial Macrolide Resistance Is Present in Both 23S rRNA Genes of an Erythromycin-ResistantTreponema pallidum Clinical Isolate

Macrolide resistance usually results from target site alteration due to methylation or mutations in the peptidyltransferase region of 23S rRNA in bacteria that contain one or two copies of these genes, and this observation prompted us to analyze the corresponding regions of the two23S r RNA genes of T. pallidum Nichols strain.

The control of endemic treponematoses.

One important factor has been the failure of many countries to integrate active control measures into local health services after the mass campaigns and incidence of yaws and endemic syphilis have returned to high levels.